- Home
- ICCC vs GCTS Comparison
ICCC vs GCTS Comparison
Compare ICCC & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- GCTS
- Stock Information
- Founded
- ICCC 1982
- GCTS 1998
- Country
- ICCC United States
- GCTS United States
- Employees
- ICCC N/A
- GCTS N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- GCTS Blank Checks
- Sector
- ICCC Health Care
- GCTS Finance
- Exchange
- ICCC Nasdaq
- GCTS Nasdaq
- Market Cap
- ICCC 61.3M
- GCTS 59.1M
- IPO Year
- ICCC 1987
- GCTS N/A
- Fundamental
- Price
- ICCC $5.90
- GCTS $1.48
- Analyst Decision
- ICCC
- GCTS Strong Buy
- Analyst Count
- ICCC 0
- GCTS 1
- Target Price
- ICCC N/A
- GCTS $5.00
- AVG Volume (30 Days)
- ICCC 27.4K
- GCTS 1.1M
- Earning Date
- ICCC 08-12-2025
- GCTS 08-13-2025
- Dividend Yield
- ICCC N/A
- GCTS N/A
- EPS Growth
- ICCC N/A
- GCTS N/A
- EPS
- ICCC N/A
- GCTS N/A
- Revenue
- ICCC $27,302,766.00
- GCTS $6,359,000.00
- Revenue This Year
- ICCC N/A
- GCTS $133.55
- Revenue Next Year
- ICCC N/A
- GCTS $347.37
- P/E Ratio
- ICCC N/A
- GCTS N/A
- Revenue Growth
- ICCC 28.29
- GCTS N/A
- 52 Week Low
- ICCC $3.34
- GCTS $0.90
- 52 Week High
- ICCC $7.60
- GCTS $5.65
- Technical
- Relative Strength Index (RSI)
- ICCC 50.09
- GCTS 60.22
- Support Level
- ICCC $6.14
- GCTS $1.35
- Resistance Level
- ICCC $6.58
- GCTS $1.53
- Average True Range (ATR)
- ICCC 0.25
- GCTS 0.14
- MACD
- ICCC -0.07
- GCTS 0.05
- Stochastic Oscillator
- ICCC 1.15
- GCTS 92.06
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About GCTS GCT Semiconductor Holding Inc. Common Stock
GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.